Discover

Back to filter

Related topics

Innovation is in its DNA

Mission Bio

Mar 22, 2024

Mission Bio’s Tapestri Tool May Hold the Key to Informing Treatment Options for Multiple Myeloma.

Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)

RareCyte

Feb 7, 2024

Samples from 82 patients with NSCLC and matched pre- and post-ICI biopsies were subjected to genomic profiling and to...

Introducing The Cytek Orion: Reagent Cocktail Preparation System

Cytek Biosciences

Jan 29, 2024

Cytek is proud to announce the Cytek Orion reagent cocktail preparation system. The Cytek Orion system allows for...

Meet new Analytik Jena qTOWERiris series

Analytik Jena

Jan 19, 2024

Thanks to a very precise thermoblock made of silver and the use of a unique, super-fast and very accurate optical...

Small animal DXA instrument comparison and validation 2024

MEDIKORS

Jan 8, 2024

This study evaluated the performance of two relatively new peripheral bone densitometry machines, the InAlyzer and the...

Flexible multiplex panel design with new Orion Reagents

RareCyte

Jan 5, 2024

Orion Reagents are tailored to enable spatial biomarker quantitation rapidly, easily and with maximum flexibility....

ScanDrop² Series: Maximum Flexibility in Micro-Volume

Analytik Jena

Nov 6, 2023

The ScanDrop2 from Analytik Jena is the second generation of microvolume spectrophotometers. It´s innovative Butterfly...

Drive key insights and discoveries with NEW Live Cell Analysis applications for eSight system

Agilent technologies

Aug 2, 2023

eSight is now powerful like never before. Learn more about new dedicated application modules for live-cell analysis: 3D...

High speed, compact and fully automated microscope inside your incubator? Lumascope850

Etaluma

Jul 13, 2023

The powerful, new LS850 Microscope is the latest generation of our fully automated three-channel flagship model and...

InAlyzer - The technology chosen by NASA

MEDIKORS

Jul 10, 2023

MEDIKORS's InAlyzer was finally selected as the equipment to be used for NASA's space environment biological research

Show all topics (10)

New ACEA kit for B cell killing

Aug 1, 2016

ACEA Biosciences, a pioneer in the development of high performance cell analysis platforms including the xCELLigence Real-Time Cell Analyzer (RTCA) instruments and NovoCyte flow cytometers, is introducing an immunotherapy kit for in vitro monitoring and quantification of effector-mediated B cell killing. This kit enables continuous real-time monitoring of B cell lymphomas as they are exposed to diverse immunotherapy approaches including NK cells, T cells, CARTs, oncolytic virus, checkpoint inhibitors, bispecific antibodies, BiTEs, etc. The major distinguishing features of this technology include enhanced sensitivity, the preclusion of labels, simple workflow and, importantly, continuous kinetic measurement of B cell cytolysis. This B cell-specific kit is the first in a series of xCELLigence immunotherapy-focused kits that ACEA will be launching in the coming months.

The utility of impedance-based xCELLigence Real-Time Cell Analysis (RTCA) for probing the efficacy of immunotherapies targeting solid/adherent cancers has been firmly established over the past decade. However, ~10% of all cancers are liquid in nature, are non-adherent and therefore cannot be directly monitored by the standard impedance assay. The B Cell Killing Assay Kit contains reagents which enable B cells to be selectively immobilized in the well bottoms of ACEA’s electronic microtiter plates. Addition of effector cells (NK, T, CART) on top of immobilized B cells results in cytolysis of target cells in an effector concentration-dependent manner. The continuous acquisition of impedance data for each well of the electronic plate allows the generation of real-time killing curves for multiple conditions simultaneously.

Dr. Yama Abassi, Vice President of ACEA Biosciences, noted that “The xCELLigence instruments provide a quantitative kinetic assessment of immune cell-mediated killing of both solid and liquid tumor cells under label-free conditions.” He further stated that “This functional assay is currently being used for evaluating/optimizing combination therapies, and for the development of adoptive cell therapies and engineered antibodies. Beyond the arena of R&D, we envision xCELLigence being utilized as a quality control assay for manufactured immuno-oncology therapies.”

Product news

Related technologies: Conventional flow cytometry

Brand profile

Agilent technologies

Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.

Related products

The best in class personalized flow cytometer

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey